Blue Whale Capital LLP Stryker Corp Transaction History

Blue Whale Capital LLP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$236.63 - $276.44 $38.6 Million - $45.1 Million	-163,200 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$248.9 - $280.09 $995,600 - $1.12 Million	4,000 Added 2.51%	163,200 $43 Million
Q2 2021 Aug 13, 2021	SELL	$242.95 - $267.0 $4.13 Million - $4.54 Million	-17,000 Reduced 9.65%	159,200 $41.3 Million
Q1 2021 May 14, 2021	SELL	$221.01 - $248.82 $2.65 Million - $2.99 Million	-12,000 Reduced 6.38%	176,200 $42.9 Million
Q4 2020 Feb 16, 2021	BUY	$202.01 - $245.04 $4.39 Million - $5.33 Million	21,750 Added 13.07%	188,200 $46.1 Million
Q3 2020 Nov 13, 2020	BUY	$177.77 - $215.81 $7.45 Million - $9.04 Million	41,900 Added 33.64%	166,450 $34.7 Million
Q2 2020 Aug 13, 2020	BUY	$144.67 - $207.03 $5.63 Million - $8.06 Million	38,950 Added 45.5%	124,550 $22.4 Million
Q1 2020 May 14, 2020	BUY	$126.5 - $225.1 $10.8 Million - $19.3 Million	85,600 New	85,600 $14.3 Million

2,232

285M

1.35M

1.6M

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $140B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

Get notified when there are updates to the investment portfolio of Blue Whale Capital LLP, based on Form 13F filings with the SEC.

Stay updated on Blue Whale Capital LLP with notifications on news.